Skip to Main Content

Author Details

Rosario I Corona
Cedars-Sinai Medical Center
2011
22
12
PMIDPaper TitleJournal TitlePublished Year
36681680Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.Nat Commun2023
37090516Rewiring of master transcription factor cistromes during high-grade serous ovarian cancer development.bioRxiv2023
35777959chromMAGMA: regulatory element-centric interrogation of risk variants.Life Sci Alliance2022
35380877The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17.Sci Signal2022
35492879A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes.Cell Rep Med2022
33137377Transcription factors in epithelial ovarian cancer: histotype-specific drivers and novel therapeutic targets.Pharmacol Ther2021
33852846Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube.Cell Rep2021
33785741Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer.Nat Commun2021
34433969A clinically applicable integrative molecular classification of meningiomas.Nature2021
34006179 <i>In vivo</i> discovery of RNA proximal proteins via proximity-dependent biotinylation.RNA Biol2021
32332753Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer.Nat Commun2020
32946763Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites.Am J Hum Genet2020
32690948Prostate cancer reactivates developmental epigenomic programs during metastatic progression.Nat Genet2020
30898391Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.Gynecol Oncol2019
31825847A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development.Cell Rep2019
31307004Super-Enhancer-Associated LncRNA UCA1 Interacts Directly with AMOT to Activate YAP Target Genes in Epithelial Ovarian Cancer.iScience2019
30577740An SVM-based method for assessment of transcription factor-DNA complex models.BMC Bioinformatics2018
27567382Protein side-chain packing problem: is there still room for improvement?Brief Bioinform2017
29312534The PAX8 cistrome in epithelial ovarian cancer.Oncotarget2017
27147539Statistical analysis of structural determinants for protein-DNA-binding specificity.Proteins2016
23220572A knowledge-based orientation potential for transcription factor-DNA docking.Bioinformatics2013
22044637Benchmarks for flexible and rigid transcription factor-DNA docking.BMC Struct Biol2011
  • 1 - 22 of 22

Recommended Authors

Emory University
Career Start Year 2009
Number of shared co-authors 0
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2009
Number of shared co-authors 16
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 19
Children's Hospital of Philadelphia
Career Start Year 2008
Number of shared co-authors 1
BC Children's Hospital Research Institute, University of British Columbia
Career Start Year 2008
Number of shared co-authors 0
University of Laval
Career Start Year 2007
Number of shared co-authors 0
Department of Immunology Erasmus University Medical Center
Career Start Year 2006
Number of shared co-authors 4
Center for Molecular Medicine, University Medical Center Utrecht
Career Start Year 2006
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
University of Illinois at Urbana-Champaign
Career Start Year 2005
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 1
Ulsan National Institute of Science and Technology (UNIST)
Career Start Year 2005
Number of shared co-authors 4
Universitat Pompeu Fabra
Career Start Year 2005
Number of shared co-authors 2
Fudan University Shanghai Cancer
Career Start Year 2004
Number of shared co-authors 2
Stanford University.
Career Start Year 2004
Number of shared co-authors 2
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 4
University of Cincinnati College of Medicine
Career Start Year 2003
Number of shared co-authors 2
Huntsman Cancer Institute, University of Utah
Career Start Year 2003
Number of shared co-authors 1
Princess Margaret Cancer Research Centre
Career Start Year 2003
Number of shared co-authors 20
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 8
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 0
Harvard Medical School
Career Start Year 2001
Number of shared co-authors 5
University of Virginia
Career Start Year 2000
Number of shared co-authors 0
IBM Thomas J Watson Research Center, University of California Los Angeles, University of North Carolina at Chapel Hill
Career Start Year 1999
Number of shared co-authors 0
The Wistar Institute
Career Start Year 1999
Number of shared co-authors 1
National Human Genome Research Institute
Career Start Year 1997
Number of shared co-authors 0
University of Florida
Career Start Year 1996
Number of shared co-authors 1
University of British Columbia
Career Start Year 1995
Number of shared co-authors 12
NTNU - Norwegian University of Science and Technology
Career Start Year 1994
Number of shared co-authors 0
University of Massachusetts Medical School
Career Start Year 1992
Number of shared co-authors 3

Collaborators

Dana-Farber Cancer Institute
Co-authored papers 10
Cedars-Sinai Medical Center
Co-authored papers 9
David Geffen School of Medicine, University of California los angeles
Co-authored papers 6
University of North Carolina at Charlotte
Co-authored papers 4
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 4
University of Pennsylvania School of Medicine
Co-authored papers 3
Dana-Farber Cancer Institute
Co-authored papers 3
University of Southern California
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Dana-Farber Cancer Institute
Co-authored papers 3
Dana-Farber Cancer Institute
Co-authored papers 3
Henry Ford Hospital
Co-authored papers 3
The Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute
Co-authored papers 2
Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem
Co-authored papers 2
University of Washington School of Medicine
Co-authored papers 2
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 2
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 2
John A. Burns School of Medicine, University of Hawaii
Co-authored papers 1
Mayo Clinic College of Medicine
Co-authored papers 1
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Pennsylvania
Co-authored papers 1
Baylor College of Medicine
Co-authored papers 1